INJS:如何应对透析患者的疲劳?

2021-11-05 小文子 MedSci原创

需要肾脏专业人员就肾病患者疲劳的复杂性进行沟通,并促进跨学科交流和共同责任。

透析患者疲劳是一个严重的健康问题,但这种症状没有得到充分的认识和治疗。发表在International Journal of Nursing Studies杂志的一项定性描述性研究,探讨护士和肾脏专业人员如何在日常保健中感知和处理透析患者的疲劳。

研究采用半结构式访谈,对21名不同学科的肾脏专业人员进行访谈,包括10名透析护士、4名肾脏病学家、2名内科助理、5名医疗社会工作者。以深入了解透析护士和肾脏专业人员的观点。以建构主义扎根理论方法指导研究结果的分析和概念化。

分析健康专业人员在日常护理环境和实践中对透析患者疲劳的见解。结果归纳了两大主题:

1)“幕后的疲劳”:更为严重且复杂的身体和医疗技术问题优先于疲劳症状,需要医务人员高度关注。所有卫生专业人员都认为疲劳是一种难以解决的无形症状,超出了他们的职责和能力范围,且疲劳本身并不影响治疗,也不意味着对患者有直接的健康风险。专业人员之间以及他们与患者之间关于疲劳的交流有限,这将疲劳进一步推到了幕后。

2)“幕后的脆弱”:护士和社会工作者表示透析患者的心理状况越来越脆弱,并将其与疲劳(高龄、多种疾病、经济和社交问题)联系起来。尽管卫生专业人员认为患者需要心理支持,但多重脆弱性增加了护理的复杂性和强度,进一步加强了以医疗技术为重点的护理和治疗。

结果表明,需要肾脏专业人员就肾病患者疲劳的复杂性进行沟通,并促进跨学科交流和共同责任。透析治疗期间,透析护士经常与患者交流,当患者疲劳加剧且整体状况恶化时,他们会首先注意到这些改变。护士可以在其中发挥重要作用,超越护理技术的必要性,并了解患者在社会环境中的生活经历。

原文出处:

Wieke E. van der Borg, Petra Verdonk, et al, How to relate to dialysis patients’ fatigue - perspectives of dialysis nurses and renal health professionals: A qualitative study, International Journal of Nursing Studies, 2021, https://doi.org/10.1016/j.ijnurstu.2021.103884.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1260946, encodeId=940b1260946da, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Nov 07 05:10:16 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570676, encodeId=0ad715e067672, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Sun Nov 07 05:10:16 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067302, encodeId=de0c106e302e4, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f471304926, createdName=xuna1110, createdTime=Fri Nov 05 15:18:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067300, encodeId=c5e3106e300e2, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0885585216, createdName=时期, createdTime=Fri Nov 05 15:11:59 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-07 tamgche
  2. [GetPortalCommentsPageByObjectIdResponse(id=1260946, encodeId=940b1260946da, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Nov 07 05:10:16 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570676, encodeId=0ad715e067672, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Sun Nov 07 05:10:16 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067302, encodeId=de0c106e302e4, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f471304926, createdName=xuna1110, createdTime=Fri Nov 05 15:18:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067300, encodeId=c5e3106e300e2, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0885585216, createdName=时期, createdTime=Fri Nov 05 15:11:59 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1260946, encodeId=940b1260946da, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Nov 07 05:10:16 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570676, encodeId=0ad715e067672, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Sun Nov 07 05:10:16 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067302, encodeId=de0c106e302e4, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f471304926, createdName=xuna1110, createdTime=Fri Nov 05 15:18:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067300, encodeId=c5e3106e300e2, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0885585216, createdName=时期, createdTime=Fri Nov 05 15:11:59 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 xuna1110

    签到

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1260946, encodeId=940b1260946da, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Nov 07 05:10:16 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570676, encodeId=0ad715e067672, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Sun Nov 07 05:10:16 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067302, encodeId=de0c106e302e4, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f471304926, createdName=xuna1110, createdTime=Fri Nov 05 15:18:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067300, encodeId=c5e3106e300e2, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0885585216, createdName=时期, createdTime=Fri Nov 05 15:11:59 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 时期

    0

相关资讯

Radiology:如何量化放射科住院医师的“疲劳”?

在过去的几十年里,诊断性影像检查的使用大大增加,放射科的工作量不断增加。在10年的时间跨度内,CT检查增加了1300%,MRI检查增加了540%。

ROY SOC OPEN SCI:使用手机社交媒体可能不会减少压力和疲劳

使用手机不仅没有缓解无聊或疲劳,在许多情况下,它使事情变得更糟。

Stroke:小儿动脉缺血性卒中后疲劳患病率和相关因素

疲劳是小儿动脉缺血性卒中后的常见问题,并且与该人群中常见的功能障碍相关。该研究强调了儿童动脉缺血性卒中后开展长期监测的重要性,以及对儿童疲劳进行有效干预的必要性。

Ann Rheum Dis:接受靶向治疗的类风湿性关节炎患者疲劳预测因素

早期RA患者的疲劳在疾病发作时普遍存在,在治疗期间迅速且持续地减少。基线时较低的客观疾病活动度和高PGA是24个月时临床相关疲劳的预测因素。

Royal Society Open Science:玩会儿手机就可缓解工作疲劳?答案竟然是NO!

当工作累了或无聊时,玩会儿手机,但智能手机真的能缓解疲劳或无聊吗

Prostate Cancer P D:恩杂鲁胺对前列腺癌患者的疲劳有什么影响?

利用四项恩杂鲁胺-安慰剂对照试验中患者报告的结果,评估了恩扎鲁胺对患者报告的疲劳的影响。